SuperAI 2025

The SuperAI conference took place in Singapore from June 18-19, 2025, at Sands Expo at Marina Bay Sands. It gathered global thought leaders, innovators, and industry experts to discuss the future of AI technology and its transformative effects on various industries. SuperAI showcased groundbreaking innovations and included the NEXT Hackathon, AMD Creator Lab, and Genesis Start-Up competition as key themes supporting the conference.

The Conference and exhibition was well dressed for this dynamic showcase with visitors hailing from various countries, and it was totally packed during all segments of the day, especially at the io.net Main Stage. Industry leaders, heads of state, entrepreneurs, esteemed researchers, and inquisitive individuals gathered in Singapore to discover and present the upcoming wave of transformative AI technologies. Super AI welcomed over 10,000 Attendees with over 1,500 AI Companies in attendance and over 150 Speakers.

The primary themes of the Conference focused on:

• Robotics

Featuring embodied AI, humanoid robotics, and advanced manufacturing

• Healthcare

Exploring AI-driven healthcare, biotechnology, and its influence on human longevity

• Finance

Investigating AI's practical uses in banking, insurance, and investment

• AI's global impact

Examining how AI transforms industry, society, policy, and ethics

Exciting Times Ahead

Some of the exciting AI developments coming from various speakers, sponsors ansd partners at the SuperAI Conference comprise Gani AI, Agora and WIZAI, Cisco, Wubble AI and HP, NYB AI.

Gani AI

Gani.AI, the specialized AI platform for legal and compliance intelligence, is introducing its proven solution at SuperAI Singapore 2025. This follows a successful international debut at SushiTech Tokyo, which generated significant industry attention.

At SuperAI, Gani.AI will launch PartnerConnect - an innovative feature that offers

context-driven connections to a vetted network of local legal experts, tax advisors, compliance professionals, and translators across all supported regions. Unlike traditional marketplace models, PartnerConnect intelligently matches users with the most suitable professionals based on specific case context and requirements, making the selection and onboarding process seamless for users while expanding revenue opportunities for professionals - creating a mutually beneficial ecosystem that transforms the platform from a tool into a comprehensive legal and compliance operating system.

Gani is the first specialized legal AI designed for the world's most complex regulatory environment, featuring a novel agentic architecture that addresses real-world cross-border challenges. It enables rapid user adoption, demonstrating enterprise AI product-market fit, and represents a $50B+ opportunity in the underserved Asia-Pacific legal tech market. It will enable multinational compliance to become a competitive advantage and addresses the shortcomings of traditional legal AI in emerging markets. As a Singapore-based company, it is poised to solve Asia-Pacific's most significant legal challenges, compete with Silicon Valley giants, and impact the regional legal services industry economically.

Agora and WIZ.AI

Agora, a global leader in real-time engagement and conversational AI technology, announced its partnership with WIZ.AI to bring enterprise-grade AI agent solutions to the market.  WIZ.AI, a leading provider of AI agents, is partnering with Agora to power enterprise-grade AI agents that offer local language support and contextual understanding to offer human-like service at scale. The collaboration blends WIZ.AI’s industry expertise in enterprise agent with Agora’s powerful real-time infrastructure and multimodal conversational AI capabilities.

With over six years of experience in localized voice AI across Southeast Asia for the banking, insurance, and telecom sectors, WIZ.AI delivers scenario-driven automation tailored to business needs. Combined with Agora’s real-time communication SDKs and Conversational AI Engine, the partnership delivers an end-to-end engagement stack—from initial contact to analytics.

Through the partnership, Agora will be integrated with WIZ.AI’s tools for:

·  Inbound Customer Service: Enterprise-grade AI agents with local language support and contextual understanding, accessible via voice and video channels

·  Outbound Campaigns: AI-driven outbound communication to boost customer activation, renewal, and retention

·  QA & Analytics: Real-time monitoring, agent performance scoring, and conversational quality control

·  AI Training & E-Learning: Virtual trainers designed to onboard staff and deliver consistent, on-demand micro-learning

Cisco

Cisco is enhancing secure infrastructure for the AI era by introducing new methods for organizations to speed up AI adoption and revolutionize IT with advanced networks, security, observability, and collaboration, aligning with the global pace of innovation.

Cisco can implement:

• Intelligent Workplaces: New devices for campus, branch, and industrial networks, paired with AI-driven unified management, to develop modern, adaptable, and secure work environments.

• Simplified Operations with AgenticOps: Cisco is introducing AI-powered solutions to streamline IT operations, boost automation, and offer proactive threat protection.

• Enhanced Security for the AI Era: Cisco is integrating AI-ready security innovations into its Hybrid Mesh Firewall and Universal Zero Trust Network Access (ZTNA) solutions, facilitating secure agentic AI adoption with the Cisco Security Cloud.

Cisco has introduced a broad array of new products and upgrades to assist customers in transitioning to agentic AI, including:

• Workplaces for the AI era

• Simplified Operations for the AI era with AgenticOps

• Data Centers for the AI era

• Security for the AI era

• Digital Resilience at the Core

• Unified Management for the AI era

WubbleAI and HP

Wubble.ai, a leading B2B ethical AI music platform, has formed a strategic partnership with HP Inc. This collaboration aims to expedite the development and distribution of responsible AI music solutions for creators, businesses, and content platforms globally.

As part of this partnership, Wubble.ai’s advanced generative music technology — designed with transparency, traceability, and rights-respecting models — will be directly integrated into select HP professional devices. This collaboration will provide an enhanced experience for music creators, marketers, game developers, and content studios looking for scalable, high-quality, and ethically-sourced AI music solutions.

The integration will first appear on select HP Z high-performance workstation computers, optimized for creative professionals. Users will have seamless access to:

• Customized, royalty-free music creation capabilities

• Enterprise and editing tools for large-scale custom sound branding

• Multimodal input for mood, tempo, and campaign-specific customization

• Seamless inference for improved privacy and real-time generation

NYB AI

Developing a new drug can require up to 15 years and cost US$2.5 billion per drug. The process starts with drug discovery, which involves reducing millions of candidates to the top ten for clinical trials. Singapore-based AI technology startup NYB.AI aims to cut the time and expense of drug discovery by up to 50% using its innovative AI model, the Drug-Target Interaction Graph Neural Network (DTIGN). This model accurately predicts the efficacy of potential drug candidates, enabling pharmaceutical companies to identify viable compounds more swiftly and confidently.

DTIGN was developed by a team of scientists at Nanyang Technological University, Singapore (NTU Singapore). It is a multidisciplinary innovation led by Associate Professor Li Hoi Yeung, an expert in cancer biology, and Associate Professor Adams Wai-Kin Kong, an expert in AI and machine learning. The new AI technology is 27% more accurate than nine leading global AI models in identifying effective molecules for drug treatment, with the potential to significantly speed up drug discovery processes.

NYB.AI is currently improving the screening process for pharmaceutical companies aiming to create more effective drugs with fewer side effects for known diseases. Pharmaceutical companies are already using AI to expedite the screening process, and DTIGN is 27% more accurate than existing AI models in predicting the potential of drug candidates to interact with disease-causing proteins. The startup expects that DTIGN’s enhanced accuracy could enable pharmaceutical companies to reduce the time and costs of drug discovery by up to 50%.

NYB.AI is pursuing commercial partnerships with pharmaceutical companies focused on drug discovery, particularly in cancer and cardiovascular research. Beyond pharmaceuticals, they aim to collaborate with universities and technological institutes involved in molecular research. These partnerships are designed to accelerate the discovery of new therapeutic compounds and improve the precision of drug design, leading to breakthroughs that could enhance patient care.

For more informati0n on SuperAI, https://www.superai.com/